Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Jade Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 70
- +14 vs. Q3 2022
- Shares held
- 27.4M
- +421.8K (+1.6%) vs. Q3 2022
- Total value
- $802.9M
- +$355.6M (+79.5%) vs. Q3 2022
- New holders
- 24
- 17 more added
- Sold out
- 10
- 22 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 4 | $0 | 0.00% | +4 | New |
| Ellevest, Inc. | 3 | $88 | 0.00% | +2+200.0% | Added |
| Federated Hermes, Inc. | 84 | $2.46K | 0.00% | +84 | New |
| Citigroup Inc | 349 | $10.2K | 0.00% | −159−31.3% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $17.8K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $20.5K | 0.00% | +701 | New |
| Tower Research Capital LLC (TRC) | 1,144 | $34.0K | 0.00% | −2,305−66.8% | Reduced |
| Russell Investments Group, Ltd. | 1,175 | $34.4K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,199 | $35.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,498 | $44.0K | 0.00% | +1,051+235.1% | Added |
| Morgan Stanley | 2,190 | $64.2K | 0.00% | −2,574−54.0% | Reduced |
| STRS Ohio | 2,300 | $67.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 3,206 | $93.9K | 0.00% | +3,206 | New |
| Legal & General Group Plc | 3,235 | $94.8K | 0.00% | +2,461+318.0% | Added |
| Deutsche Bank AG | 3,782 | $110.8K | 0.00% | +60+1.6% | Added |
| Barclays PLC | 3,870 | $113.4K | 0.00% | +3,481+894.9% | Added |
| American International Group, Inc. | 4,344 | $127.3K | 0.00% | −16−0.4% | Reduced |
| MetLife Investment Management | 5,228 | $153.2K | 0.00% | +5,228 | New |
| JPMorgan Chase & Co | 5,267 | $154.0K | 0.00% | −1,557−22.8% | Reduced |
| Bank of America Corp | 7,556 | $221.4K | 0.00% | −5,171−40.6% | Reduced |
| New York State Common Retirement Fund | 7,673 | $224.8K | 0.00% | −13−0.2% | Reduced |
| Old Well Partners, LLC | 8,092 | $237.1K | 0.21% | +8,092 | New |
| State of Wisconsin Investment Board | 8,567 | $251.0K | 0.00% | +8,567 | New |
| Credit Suisse AG | 9,071 | $265.8K | 0.00% | +9,021+18,042.0% | Added |
| California State Teachers Retirement System | 11,081 | $324.7K | 0.00% | +7,456+205.7% | Added |
| Trustees of Columbia University in the City of New York | 13,190 | $386.0K | 0.80% | +13,190 | New |
| Price T Rowe Associates Inc | 13,225 | $387.0K | 0.00% | +13,225 | New |
| Rhumbline Advisers | 14,232 | $417.0K | 0.00% | +90+0.6% | Added |
| Nantahala Capital Management, LLC | 15,700 | $460.0K | 0.04% | +15,700 | New |
| Alps Advisors Inc | 16,685 | $488.9K | 0.00% | +16,685 | New |
| Renaissance Technologies LLC | 18,100 | $530.0K | 0.00% | +18,100 | New |
| Cheyne Capital Management (UK) LLP | 18,927 | $554.6K | 0.98% | +18,927 | New |
| Parkwood LLC | 20,560 | $602.0K | 0.12% | −784−3.7% | Reduced |
| Swiss National Bank | 20,701 | $606.5K | 0.00% | +20,701 | New |
| Two Sigma Investments, LP | 21,137 | $619.3K | 0.00% | +21,137 | New |
| Ensign Peak Advisors, Inc | 21,208 | $621.4K | 0.00% | +21,208 | New |
| Charles Schwab Investment Management Inc | 24,641 | $722.0K | 0.00% | +885+3.7% | Added |
| Boothbay Fund Management, LLC | 25,813 | $756.3K | 0.03% | −9,944−27.8% | Reduced |
| Bank of New York Mellon Corp | 28,094 | $823.2K | 0.00% | +548+2.0% | Added |
| D. E. Shaw & Co., Inc. | 29,494 | $864.2K | 0.00% | −4,801−14.0% | Reduced |
| Silverarc Capital Management, LLC | 36,906 | $1.08M | 0.37% | +36,906 | New |
| Nuveen Asset Management, LLC | 37,112 | $1.09M | 0.00% | +2,136+6.1% | Added |
| Nan Fung Group Holdings Ltd | 50,616 | $1.48M | 1.02% | +50,616 | New |
| Skandinaviska Enskilda Banken AB (publ) | 53,340 | $1.56M | 0.01% | −3,091−5.5% | Reduced |
| Invesco Ltd. | 72,579 | $2.13M | 0.00% | +72,579 | New |
| Northern Trust Corp | 78,199 | $2.29M | 0.00% | +3,371+4.5% | Added |
| Eversept Partners, LP | 91,252 | $2.67M | 0.25% | +91,252 | New |
| Millennium Management LLC | 123,208 | $3.61M | 0.00% | +39,578+47.3% | Added |
| Ikarian Capital, LLC | 127,921 | $3.75M | 1.56% | −72,079−36.0% | Reduced |
| Ghost Tree Capital, LLC | 135,000 | $3.96M | 1.69% | −15,000−10.0% | Reduced |
| Fred Alger Management, LLC | 147,955 | $4.34M | 0.02% | −34,326−18.8% | Reduced |
| Point72 Asset Management, L.P. | 175,022 | $5.13M | 0.02% | +175,022 | New |
| Geode Capital Management, LLC | 178,596 | $5.23M | 0.00% | +8,997+5.3% | Added |
| State Street Corp | 192,184 | $5.63M | 0.00% | +19,006+11.0% | Added |
| Soleus Capital Management, L.P. | 217,119 | $6.36M | 0.91% | +217,119 | New |
| Great Point Partners LLC | 378,522 | $11.1M | 2.29% | +378,522 | New |
| FMR LLC | 457,187 | $13.4M | 0.00% | −67,873−12.9% | Reduced |
| Vanguard Group Inc | 499,477 | $14.6M | 0.00% | +33,245+7.1% | Added |
| OUP Management Co., LLC | 603,762 | $17.7M | 28.88% | 00.0% | Unchanged |
| BlackRock Inc. | 607,983 | $17.8M | 0.00% | −107,462−15.0% | Reduced |
| Octagon Capital Advisors LP | 621,712 | $18.2M | 2.84% | +621,712 | New |
| VR Adviser, LLC | 747,869 | $21.9M | 3.69% | −86,058−10.3% | Reduced |
| OrbiMed Advisors LLC | 759,540 | $22.3M | 0.43% | −35,460−4.5% | Reduced |
| TCG Crossover Management, LLC | 1,081,274 | $31.7M | 5.59% | +121,702+12.7% | Added |
| Citadel Advisors LLC | 1,561,923 | $45.8M | 0.05% | −53,655−3.3% | Reduced |
| Cormorant Asset Management, LP | 1,957,132 | $57.3M | 3.85% | −373,559−16.0% | Reduced |
| Baker Bros. Advisors LP | 1,976,868 | $57.9M | 0.35% | −2,700−0.1% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59.1M | 7.12% | −310,388−13.3% | Reduced |
| Sofinnova Investments, Inc. | 3,758,686 | $110.1M | 6.69% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $242.1M | 4.91% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −276,447−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −51,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −46,864−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,574−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −3,962−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,612−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −28−100.0% | Sold out |